España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
OncoCyte
OCX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.45
0.15
6.52%
At close: -
$2.30
-0.15
-6.12%
After Hours: 7:12 PM EDT
Get Report
Comment
OncoCyte (OCX) Forecast
News
Earnings
OncoCyte (OCX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for OncoCyte (NASDAQ:OCX) Stock
OncoCyte Stock (NASDAQ: OCX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 04, 2024
Oncocyte Corp shares are trading higher after...
Benzinga Newsdesk
Oncocyte Announces Publication Of Data Regard...
Benzinga Newsdesk
Monday, December 02, 2024
Oncocyte  Announces Additional Favorable Data...
Benzinga Newsdesk
Wednesday, November 13, 2024
Needham Reiterates Buy on OncoCyte, Maintains...
Benzinga Newsdesk
Tuesday, November 12, 2024
OncoCyte Q3 2024 Adj. EPS $(0.41) Beats $(0.4...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
What to Expect from OncoCyte's Earnings
Benzinga Insights
Tuesday, October 15, 2024
Needham Reiterates Buy on OncoCyte, Maintains...
Benzinga Newsdesk
Tuesday, October 08, 2024
Oncocyte's DetermaIO Immuno-Oncology Assay Pr...
Benzinga Newsdesk
Thursday, October 03, 2024
Reported Earlier, Oncocyte Announces $10.2M P...
Benzinga Newsdesk
Reported Earlier, Oncocyte Signs Leading U.S....
Benzinga Newsdesk
Monday, August 12, 2024
Oncocyte Publishes Case Series Highlighting T...
Benzinga Newsdesk
Friday, August 09, 2024
Needham Reiterates Buy on OncoCyte, Maintains...
Benzinga Newsdesk
Thursday, August 08, 2024
OncoCyte Q2 2024 GAAP EPS $(0.36) Beats $(0.5...
Benzinga Newsdesk
Monday, June 17, 2024
Oncocyte Appoints Andrea James As CFO
Benzinga Newsdesk
Monday, June 03, 2024
Oncocyte's VitaGraft Kidney Diagnostic Test S...
Benzinga Newsdesk
Thursday, May 30, 2024
Oncocyte VitaGraft Kidney Study Results Publi...
Benzinga Newsdesk
Thursday, May 16, 2024
4 Analysts Assess OncoCyte: What You Need To Know
Benzinga Insights
Needham Reiterates Buy on OncoCyte, Maintains...
Benzinga Newsdesk
Wednesday, May 15, 2024
OncoCyte Q1 2024 GAAP EPS $(1.13) Misses $(0....
Benzinga Newsdesk
Wednesday, April 24, 2024
Needham Maintains Buy on OncoCyte, Raises Pri...
Benzinga Newsdesk
Tuesday, April 23, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, April 22, 2024
Bio-Rad Laboratories Inc Reports 8.99% Passiv...
Benzinga Newsdesk
Wednesday, April 17, 2024
Stephens & Co. Reiterates Equal-Weight on Onc...
Benzinga Newsdesk
Monday, April 15, 2024
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Benchmark Reiterates Speculative Buy on OncoC...
Benzinga Newsdesk
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, April 12, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Oncocyte shares are trading higher after the ...
Benzinga Newsdesk
Top 3 Health Care Stocks That May Collapse In Q2
Avi Kapoor
Earnings Scheduled For April 12, 2024
Benzinga Insights
OncoCyte Q4 EPS $(2.18) Misses $(1.14) Estima...
Benzinga Newsdesk
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Reported Earlier, Oncocyte Prices $15.8M Priv...
Benzinga Newsdesk
Thursday, April 11, 2024
Oncocyte Announces Partnership Agreement With...
Benzinga Newsdesk
Wednesday, December 06, 2023
Oncocyte Begins FDA Single-Site Process For I...
Benzinga Newsdesk
Monday, November 13, 2023
Piper Sandler Maintains Neutral on OncoCyte, ...
Benzinga Newsdesk
Thursday, November 09, 2023
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Needham Maintains Buy on OncoCyte, Lowers Pri...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
OncoCyte Q3 Sales $429.00K Beat $330.00K Esti...
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights
Wednesday, November 08, 2023
OncoCyte's Earnings: A Preview
Benzinga Insights
Wednesday, October 25, 2023
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, September 18, 2023
Oncocyte Announced The Presentation Of New Cl...
Benzinga Newsdesk
Friday, September 15, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, August 28, 2023
Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage; Expect Initial Revenue Generation In Q1 2024
Happy Mohamed
Thursday, August 24, 2023
Benchmark Maintains Speculative Buy on OncoCy...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch